Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation

BACKGROUND: We sought to evaluate the incidence and clinical impact of luteinizing hormone (LH) rises prior to and during gonadotropin-releasing hormone (GnRH) antagonist treatment started on day 5 or 6 of ovarian stimulation with recombinant follicle-stimulating hormone (rFSH). METHODS: Pooled data...

Descripción completa

Detalles Bibliográficos
Autores principales: Frattarelli, John L, Hillensjö, Torbjörn, Broekmans, Frank J, Witjes, Han, Elbers, Jolanda, Gordon, Keith, Mannaerts, Bernadette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847921/
https://www.ncbi.nlm.nih.gov/pubmed/24028076
http://dx.doi.org/10.1186/1477-7827-11-90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847921/
https://www.ncbi.nlm.nih.gov/pubmed/24028076
http://dx.doi.org/10.1186/1477-7827-11-90

Ejemplares similares